Yield10 Bioscience, Inc. (YTEN)

OTCMKTS: YTEN · Delayed Price · USD
0.830
0.00 (0.00%)
Jul 16, 2024, 10:01 AM EDT - Market open
Market Cap 533.31K
Revenue (ttm) 360,000
Net Income (ttm) -13.15M
Shares Out 642.55K
EPS (ttm) -36.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,004
Open 0.830
Previous Close 0.830
Day's Range n/a
52-Week Range 0.800 - 54.480
Beta 1.38
Analysts Buy
Price Target 54.00 (+6,406.02%)
Earnings Date May 15, 2024

About YTEN

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscienc... [Read more]

Sector Materials
IPO Date Nov 10, 2006
Employees 29
Stock Exchange OTCMKTS
Ticker Symbol YTEN
Full Company Profile

Financial Performance

In 2023, YTEN's revenue was $60,000, a decrease of -86.67% compared to the previous year's $450,000. Losses were -$14.46 million, 6.55% more than in 2022.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for YTEN stock is "Buy." The 12-month stock price forecast is $54.0, which is an increase of 6,406.02% from the latest price.

Price Target
$54.0
(6,406.02% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina

Engineered Camelina is intended to enable the land-based production of omega-3 oils used in aquafeed, petfood and human nutrition Engineered Camelina is intended to enable the land-based production of...

4 weeks ago - GlobeNewsWire

Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label

- EPA approved an amendment to the label of INTERLINE herbicideto include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., ...

7 weeks ago - GlobeNewsWire

Yield10 Bioscience Announces First Quarter 2024 Financial Results

-Earns $1 million in milestone payments from Vision Bioenergy Oilseeds -Earns $1 million in milestone payments from Vision Bioenergy Oilseeds

2 months ago - GlobeNewsWire

Yield10 Bioscience Announces Delisting from Nasdaq

WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that Company has received a fin...

2 months ago - GlobeNewsWire

Yield10 Bioscience Announces 1-for-24 Reverse Stock Split

WOBURN, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that it will effect a 1-for-24 ...

2 months ago - GlobeNewsWire

Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results

-Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market -Advanced regulatory and seed scale-up program for omega-3 Camelina -E3902 oil trait in Camelina clear...

3 months ago - GlobeNewsWire

Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024

WOBURN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report ...

3 months ago - GlobeNewsWire

Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada

WOBURN, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today reported that the Plant Biosafety Offic...

4 months ago - GlobeNewsWire

USDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United States

Yield10 Bioscience achieves significant milestone enabling ramp-up to commercial scale production of omega-3 fatty acids in Camelina in the United States.

4 months ago - GlobeNewsWire

Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests

-Herbicide tolerance is critical to planting the Camelina crop on large acreage for the biofuel and omega-3 oil markets -Herbicide tolerance is critical to planting the Camelina crop on large acreage ...

4 months ago - GlobeNewsWire

Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock

Global License of Industry-Leading Elite Herbicide Tolerant Camelina Accelerates Biofuel Feedstock Production Global License of Industry-Leading Elite Herbicide Tolerant Camelina Accelerates Biofuel F...

5 months ago - GlobeNewsWire

Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program

-Prioritizes Activities to Advance Omega-3 Camelina Program in 2024 -Reports Completion of Contra Season Production of Omega-3 Camelina Seed in Chile - Company also Provides Update on Nasdaq Status - ...

5 months ago - GlobeNewsWire

Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil

WOBURN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company recently file...

6 months ago - GlobeNewsWire

USDA-APHIS Determines that Yield10 Bioscience's Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States

-Herbicide Technology Critical to Enabling Large-Acreage Adoption of Camelina in North America -Herbicide Technology Critical to Enabling Large-Acreage Adoption of Camelina in North America

8 months ago - GlobeNewsWire

USDA-APHIS Determines that Yield10 Bioscience's Glufosinate Tolerant Camelina May Be Planted and Bred in the United States

-Yield10 Achieves a Significant Milestone in the Development  of Camelina as a Commercial Crop for Producing Biofuels and Omega-3 Oils

8 months ago - GlobeNewsWire

Yield10 Bioscience Announces Third Quarter 2023 Financial Results

-Establishes "Camelina Seed Genetics to Biofuel" Platform -Advances Herbicide Tolerant Camelina Varieties toward Commercialization -Exercises Option to Finalize Exclusive, Global Commercial License to...

8 months ago - GlobeNewsWire

Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023

WOBURN, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report i...

8 months ago - GlobeNewsWire

Yield10 Bioscience and BioMar Aim to Grow Fish Oil on Land

Yield10 Bioscience and BioMar Group have signed an LOI to form a long-term partnership to commercialize a Camelina crop containing enriched levels of EPA and DHA equal to fish oil. After a decade of r...

9 months ago - GlobeNewsWire

Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research

WOBURN, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has exercised...

9 months ago - GlobeNewsWire

Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina

-On track for commercial launch of first herbicide tolerant Camelina variety as early as 2025 -First field tests of stacked herbicide tolerant winter Camelina underway -Recent positive field tests dem...

9 months ago - GlobeNewsWire

Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production

Begins revenue generation for “Camelina Seed Genetics to Biofuel” platform Begins revenue generation for “Camelina Seed Genetics to Biofuel” platform

10 months ago - GlobeNewsWire

Yield10 Bioscience to Present at the H.C. Wainwright 25th Annual Global Investment Conference

WOBURN, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that management will partici...

11 months ago - GlobeNewsWire

Yield10 Bioscience Announces Closing of $3.7 Million Public Offering

WOBURN, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced the closing of its previously ...

11 months ago - GlobeNewsWire

Yield10 Bioscience Announces Second Quarter 2023 Financial Results

-Harvesting underway for contracted winter and spring Camelina acres for the biofuels market -Reported positive results in first field tests of stacked herbicide tolerant Camelina -Filed a request for...

1 year ago - GlobeNewsWire

Yield10 Bioscience to Announce Second Quarter 2023 Financial Results and Host a Conference Call on Monday, August 14, 2023

WOBURN, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report i...

1 year ago - GlobeNewsWire